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fd. Note - This overview was originally presented at the 
International Symposium on Clinical Disorders of Bone 
and Mineral Metabolism, May 9-13,1983. The following 
list indicates the presentations given in this session at the 
Symposium and the contents ofthe corresponding chap-
ter in the Proceedings of the Symposium published by 
Excerpta Medica. The numbers in parentheses refer to 
pages in this volume. Complete information about the 
contents ofthe Proceedings can be found at the back of 
this issue. 
Cell biology o f the parathyroid gland and its relationship 
to hyperplasia. L.M. Sherwood, J. Russell, and G. Bhar-
gava (131) 
The two-hit theory of neoplasia: Implications for the 
pathogenesis of hyperparathyroidism. C.E.Jackson (135) 
The interaction between abnormal cellular prol i feration 
and secretion in primary hyperparathyroidism. E.M. 
Brown, M.S. LeBoff, D. Shoback, and R.E. Wilson (139) 
W i t h the advent of routine screening procedures for 
serum calcium, primary hyperparathyroidism has been 
recognized as an extraordinari ly common disorder, 
increasing in frequency in the elderly. Secondary 
hyperparathyroidism, which is associated wi th chronic 
renal fai lure, may also occur in patients wi th malab-
sorpt ion, vitamin D deficiency, and other causes of low 
serum calcium. The papers in this session dealt wi th 
various aspects of normal parathyroid cell biology and 
biochemistry as well as abnormalit ies ident i f ied in 
hyperplastic or adenomatous glands. Al though recog-
nit ion of the clinical disorders is relatively straightfor-
ward and diagnosis by radioimmunoassay relatively 
simple (despite the caveats of PTH radioimmunoassay), 
much needs to be learned about normal and abnormal 
control mechanisms, as well as pathogenetic factors, 
particularly in primary hyperparathyroidism. 
During the past two decades, PTH from humans, the 
cow, and a number of other species has been purif ied 
and sequenced, and the critical features of peptide struc-
ture necessary for biologic activity determined (Fig. 1). 
The biosynthesis of hormone and its precursor forms has 
been elaborated, the precursor has been synthesized in 
cell-free systems, and the complete sequence of DNA 
coding for hormonal mRNA has been identif ied. These 
issues were reviewed in the discussion by Sherwood and 
colleagues (pp. 131 ff.). Extraordinarily little information 
is available at present about control mechanisms operat-
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ing at the biosynthetic level, but our laboratory has pro-
vided the first evidence for a direct effect of calicum on 
levels of pre-pro PTH mRNA in the parathyroid cell (J 
Clin Invest, in press). A great deal of new information 
needs to be obtained, but the sophisticated tools of 
molecular biology are readily available, and these issues 
should be understood more clearly in the near future. A 
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paucity of data exists on the regulation of biosynthetic 
mechanisms in normal glands, but no data exist at all on 
these issues in adenomatous or hyperplastic glands. That 
should also be forthcoming. 
The regulation of hormone secretion has been explored 
extensively in vitro and in vivo by many workers, includ-
ing Sherwood, Brown, Cohn, Fischer, Mayer, Aurbach, 
Potts, Will iams, and others. Brown, et al (pp. 139 ff.) 
reviewed the use of isolated parathyroid cells to study 
aspects of normal and abnormal secretion; they dis-
cussed the defini t ion of parameters of secretion such as 
maximal secretory rate, set point, slope o f the curve at its 
midpoint, and minimal secretory rate. It has been well 
documented that minimal secretion occurs both in vivo 
and in vitro despite calcium concentrations higher than 
normal. This factor contributes to the overall secretory 
rate in hyperparathyroidism. Increases in set point (the 
calcium level at which 50% suppression of PTH secretion 
occurs) in some patients with primary hyperparathyroid-
ism is considered a significant factor in the oversecretion 
of hormone. Both set point and minimal secretory rate 
are related to cell number. Agents other than low cal-
cium have been identified as secretogogues for PTH, 
including beta agonists, dopamine, histamine, secretin, 
and prostaglandins. These appear to act through adeny-
late cyclase and cyclic AMP, but their physiologic impor-
tance has not been defined. Likewise, failure to demon-
strate convincingly that beta blockers or histamine 
receptor antagonists are useful in control l ing secretion 
of hormone on a chronic basis lessens the potential 
therapeutic significance of these agents. Mechanisms 
are being defined by which low calcium, other divalent 
cations such as magnesium, and other agonists which 
activate cyclic AMP stimulate PTH secretion. Data on the 
interaction of calcium and other regulators in abnormal 
parathyroid glands are incomplete. 
Finally, little information is available about the regula-
tion of cell growth and number, either benign (hyper-
plasia, adenoma) or malignant (carcinoma). Jackson (pp. 
135 ff.) described an interesting means of assessing 
pathogenesis through the measurement of glucose 6-
phosphate hydrogenase in parathyroid adenomas. A l -
though these fascinating studies suggest that adenomas 
are polyclonal and imply that stimulatory factors may 
lead to primary hyperplasia, the nature of such factors is 
very obscure. The only known stimulus to parathyroid 
hyperplasia is a low serum calcium. Hyperplasia, readily 
produced in animals maintained on a low calcium diet, 
occurs in patients with renal failure and other disorders 
such as malabsorption or vitamin D deficiency in which 
the serum calcium is low. These patients have low or 
normal serum calcium unless marked hyperplasia o f the 
glands causes a hypercalcemic state. This unusual occur-
rence has been described in both chronic renal failure 
and in malabsorption, but the hypercalcemia that occurs 
in the postrenal transplant state is much more common. 
In these individuals, who have developed marked hyper-
trophy and hyperplasia of their glands secondary to 
hypocalcemia and vitamin D deficiency and have resist-
ance to PTH action, renal function is corrected by trans-
plantation. With the loss of resistance to PTH action and 
the restoration of normal vitamin D metabolism, hyper-
calcemia commonly results. Usually, the parathyroid 
tissue is not functionally autonomous but behaves like 
hyperplastic glands. In many of these patients the para-
thyroid hyperplasia persists for years after renal trans-
plantation. Once developed, the hyperplastic glands 
may never regress completely. We know very little about 
the factors that generate parathyroid hyperplasia, par-
ticularly at the subcellular or membrane level, or about 
the factors that might lead to regression. 
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